Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Human Bone Marrow Stromal Cells Differentiate into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice

  • Sánchez Abarca, Luis Ignacio
  • Hernández Galilea, Emiliano
  • Lorenzo, Rebeca
  • Herrero, Carmen
  • Velasco, Almudena
  • Carrancio, Soraya
  • Caballero Velázquez, Teresa
  • Rodríguez Barbosa, José Ignacio
  • Parrilla, Marta
  • Cañizo, Consuelo del
  • San Miguel, Jesús
  • Aijón, José
  • Pérez Simón, José Antonio
[EN] Clinical trials have assessed the use of human bone marrow stromal cells (hBMSCs) for the treatment of immune-related disorders such as graft-versus-host disease (GVHD). In the current study, we show that GFP+-transduced hBMSCs generated from bone marrow migrate and differentiate into corneal tissue after subconjunctival injection in mice. Interestingly, these hBMSCs display morphological features of epithelial, stromal, and endothelial cells and appear at different layers and with different morphologies epending on their position within the epithelium. Furthermore, these cells display ultrastructural properties, such as bundles of intermediate filaments, interdigitations, and desmosomes with GFP− cells, which confirms their differentiation into corneal tissues. GFP+-transduced hBMSCs were injected at different time points into the right eye of lethally irradiated mice undergoing bone marrow transplantation, which developed ocular GVHD (oGVHD). Remarkably, hBMSCs massively migrate to corneal tissues after subconjunctival injection. Both macroscopic and histopathological examination showed minimal or no evidence of GVHD in the right eye, while the left eye, where no hBMSCs were injected, displayed features of GVHD. Thus, in the current study, we confirm that hBMSCs may induce their therapeutic effect at least in part by differentiation and regeneration of damaged tissues in the host. Our results provide experimental evidence that hBMSCs represent a potential cellular therapy to attenuate oGVHD, SI, The authors would like to thank Didier Trono for pWPI vector plasmid. Teresa Caballero was supported by a Rio Hortega grant (code: CM10/00161) from Instituto de Salud Carlos III. We thank R. Sánchez and M. T. Sánchez for their technical assistance. We would like to thank Dr. Anton Martens, from the University Medical Center Utrecht, for providing the vectors for GFP assays. This study was partially supported by grants from FIS (PI11/02366 and PI12/00939) and Junta de Castilla y León (GR 183). The authors declare no conflicts of interest
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition

  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Khannous-Lleiffe, Olfat
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Willis, Jesse R.
  • Salvo-Romero, Eloísa
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • Fortea, Marina|||0000-0001-8885-7495
  • Pardo-Camacho, Cristina
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Martínez, Cristina|||0000-0002-9368-1356
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Vicario Perez, Maria|||0000-0001-9622-3185
  • Santos, Javier|||0000-0002-4798-5033
  • Gabaldón, Toni|||0000-0003-0019-1735
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
Digestive disorders of gut-brain interaction (DGBI) are very common, predominant in females, and usually associated with intestinal barrier dysfunction, dysbiosis, and stress. We previously found that females have increased susceptibility to intestinal barrier dysfunction in response to acute stress. However, whether this is associated with changes in the small bowel microbiota remains unknown. We have evaluated changes in the small intestinal microbiota in response to acute stress to better understand stress-induced intestinal barrier dysfunction. Jejunal biopsies were obtained at baseline and 90 min after cold pain or sham stress. Autonomic (blood pressure and heart rate), hormonal (plasma cortisol and adrenocorticotropic hormone) and psychological (Subjective Stress Rating Scale) responses to cold pain and sham stress were monitored. Microbial DNA from the biopsies was analyzed using a 16S metabarcoding approach before and after cold pain stress and sham stress. Differences in diversity and relative abundance of microbial taxa were examined. Cold pain stress was associated with a significant decrease in alpha diversity (P = 0.015), which was more pronounced in females, along with significant sex differences in the abundance of specific taxa and the overall microbiota composition. Microbiota alterations significantly correlated with changes in psychological responses, hormones, and gene expression in the intestinal mucosal. Cold pain stress was also associated with activation of autonomic, hormonal and psychological response, with no differences between sexes. Acute stress elicits rapid alterations in bacterial composition in the jejunum of healthy subjects and these changes are more pronounced in females. Our results may contribute to the understanding of female predominance in DGBI.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Genetic polymorphisms located in genes related to immune and inflammatory processes are associated with end-stage renal disease: a preliminary study

  • Jimenez-Sousa, Mª Angeles
  • López, Elisabeth
  • Fernandez-Rodriguez, Amanda
  • Tamayo, Eduardo
  • Fernández-Navarro, Pablo
  • Segura Roda, Laura
  • Heredia, Maria
  • Gómez-Herreras, José I.
  • Bustamante, Jesus
  • Bermejo-Martin, Jesus F.
  • Garcia-Gomez, Juan M
  • Resino, Salvador
Background Chronic kidney disease progression has been linked to pro-inflammatory cytokines and markers of inflammation. These markers are also elevated in end-stage renal disease (ESRD), which constitutes a serious public health problem. Objective To investigate whether single nucleotide polymorphisms (SNPs) located in genes related to immune and inflammatory processes, could be associated with ESRD development. Design and methods A retrospective case-control study was carried out on 276 patients with ESRD and 288 control subjects. Forty-eight SNPs were genotyped via SNPlex platform. Logistic regression was used to assess the relationship between each sigle polymorphism and the development of ESRD. Results Four polymorphisms showed association with ESRD: rs1801275 in the interleukin 4 receptor (IL4R) gene (OR: 0.66 (95%CI=0.46-0.95); p=0.025; overdominant model), rs4586 in chemokine (C-C motif) ligand 2 (CCL2) gene (OR: 0.70 (95%CI=0.54-0.90); p=0.005; additive model), rs301640 located in an intergenic binding site for signal transducer and activator of transcription 4 (STAT4) (OR: 1.82 (95%CI=1.17-2.83); p=0.006; additive model) and rs7830 in the nitric oxide synthase 3 (NOS3) gene (OR: 1.31 (95%CI=1.01-1.71); p=0.043; additive model). After adjusting for multiple testing, results lost significance. Conclusion Our preliminary data suggest that four genetic polymorphisms located in genes related to inflammation and immune processes could help to predict the risk of developing ESRD., This work was supported by grants from Instituto de Salud Carlos III (Ref: PI08/0738 and PI11/00245) to SR and Junta de Castilla y Leon (Ref: GRS 234/A/08) to ET. MAJS is supported by a grant from Instituto de Salud Carlos III (CM10/00105).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Investigating silent strokes in hypertensives, a magnetic resonance imaging study (ISSYS): rationale and protocol design

  • Riba Llena, Iolanda
  • Jarca, Carmen Ioana
  • Mundet-Tudurí, Xavier|||0000-0002-0318-8657
  • Tovar, Jose L.
  • Orfila, Francesc|||0000-0002-2409-1731
  • López-Rueda, Antonio
  • Nafría, Cristina
  • Fernández, Jose L.
  • Castañé, Xavier
  • Domingo, Mar|||0000-0002-2935-1272
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Fernández-Cortiñas, Inés
  • Maisterra Santos, Olga
  • Montaner, Joan|||0000-0003-4845-2279
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
Silent brain infarcts are detected by neuroimaging in up to 20% of asymptomatic patients based on population studies. They are five times more frequent than stroke in general population, and increase significantly both with advancing age and hypertension. Moreover, they are independently associated with the risk of future stroke and cognitive decline. Despite these numbers and the clinical consequences of silent brain infarcts, their prevalence in Mediterranean populations is not well known and their role as predictors of future cerebrovascular and cardiovascular events in hypertensive remains to be determined. ISSYS (Investigating Silent Strokes in Hypertensives: a magnetic resonance imaging study) is an observational cross-sectional and longitudinal study aimed to: 1- determine the prevalence of silent cerebrovascular infarcts in a large cohort of 1000 hypertensives and to study their associated factors and 2-to study their relationship with the risk of future stroke and cognitive decline. Cohort study in a randomly selected sample of 1000 participants, hypertensive aged 50 to 70 years old, with no history of previous stroke or dementia. On baseline all participants will undergo a brain MRI to determine the presence of brain infarcts and other cerebrovascular lesions (brain microbleeds, white matter changes and enlarged perivascular spaces) and will be also tested to determine other than brain organ damage (heart-left ventricular hypertrophy, kidney-urine albumin to creatinine ratio, vessels-pulse wave velocity, ankle brachial index), in order to establish the contribution of other subclinical conditions to the risk of further vascular events. Several sub-studies assessing the role of 24 hour ambulatory BP monitoring and plasma or genetic biomarkers will be performed. Follow-up will last for at least 3 years, to assess the rate of further stroke/transient ischemic attack, other cardiovascular events and cognitive decline, and their predictors. Improving the knowledge on the frequency and determinants of these lesions in our setting might help in the future to optimize treatments or establish new preventive strategies to minimize clinical and socioeconomic consequences of stroke and cognitive decline.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Neurofilament light chain level is a weak risk factor for the development of MS

  • Arrambide, Georgina|||0000-0002-2657-5510
  • Espejo, Carmen|||0000-0001-9949-5901
  • Eixarch, Herena|||0000-0001-7525-9533
  • Villar, Luisa M.|||0000-0002-9067-3668
  • Alvarez-Cermeño, José C.|||0000-0002-1345-2837
  • Picón, Carmen
  • Kuhle, Jens|||0000-0002-6963-8892
  • Disanto, Giulio
  • Kappos, Ludwig|||0000-0003-4175-5509
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Pareto, Deborah|||0000-0001-7356-3769
  • Simon, Eva
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Río, Jordi|||0000-0003-4546-7627
  • Nos, Carlos|||0000-0002-3830-4910
  • Tur, Carmen|||0000-0003-1849-3184
  • Castilló, Joaquín|||0000-0002-8951-6315
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Galan, Ingrid|||0000-0001-5774-4260
  • Arévalo, María Jesús|||0000-0003-0626-5555
  • Auger, Cristina|||0000-0001-9846-4767
  • Rovira, Alex|||0000-0002-2132-6750
  • Montalban, Xavier|||0000-0002-0098-9918
  • Tintoré, Mar|||0000-0001-9999-5359
To determine the prognostic value of selected biomarkers in clinically isolated syndromes (CIS) for conversion to multiple sclerosis (MS) and disability accrual. Data were acquired from 2 CIS cohorts. The screening phase evaluated patients developing clinically definite MS (CIS-CDMS) and patients who remained as CIS during a 2-year minimum follow-up (CIS-CIS). We determined levels of neurofascin, semaphorin 3A, fetuin A, glial fibrillary acidic protein, and neurofilament light (NfL) and heavy chains in CSF (estimated mean [95% confidence interval; CI]). We evaluated associations between biomarker levels, conversion, disability, and magnetic resonance parameters. In the replication phase, we determined NfL levels (n = 155) using a 900 ng/L cutoff. Primary endpoints in uni- and multivariate analyses were CDMS and 2010 McDonald MS. The only biomarker showing significant differences in the screening was NfL (CIS-CDMS 1,553.1 [1,208.7-1,897.5] ng/L and CIS-CIS 499.0 [168.8-829.2] ng/L, p < 0.0001). The strongest associations were with brain parenchymal fraction change (r = -0.892) and percentage brain volume change (r = -0.842) at 5 years. NfL did not correlate with disability. In the replication phase, more NfL-positive patients, according to the cutoff, evolved to MS. Every 100-ng/L increase in NfL predicted CDMS (hazard ratio [HR] = 1.009, 95% CI 1.005-1.014) and McDonald MS (HR = 1.009, 95% CI 1.005-1.013), remaining significant for CDMS in the multivariate analysis (adjusted HR = 1.005, 95% CI 1.000-1.011). This risk was lower than the presence of oligoclonal bands or T2 lesions. NfL is a weak independent risk factor for MS. Its role as an axonal damage biomarker may be more relevant as suggested by its association with medium-term brain volume changes.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Lesion topographies in multiple sclerosis diagnosis

  • Arrambide, Georgina|||0000-0002-2657-5510
  • Tintoré, Mar|||0000-0001-9999-5359
  • Auger, Cristina|||0000-0001-9846-4767
  • Río, Jordi|||0000-0003-4546-7627
  • Castilló, Joaquín|||0000-0002-8951-6315
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Galan, Ingrid|||0000-0001-5774-4260
  • Nos, Carlos|||0000-0002-3830-4910
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Mitjana, Raquel|||0000-0002-2076-9461
  • Mulero, Patricia|||0000-0001-8716-8997
  • de Barros, Andrea
  • Rodríguez Acevedo, Breogán|||0000-0002-0314-753X
  • Midaglia, Luciana|||0000-0001-7981-2228
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Rovira, Alex|||0000-0002-2132-6750
  • Montalban, Xavier|||0000-0002-0098-9918
To assess the contributions of cortico-juxtacortical and corpus callosum lesions to multiple sclerosis diagnosis and to compare the value of ≥1 vs ≥3 periventricular lesions in clinically isolated syndromes (CIS). Step 1: We evaluated lesion topography classifications in 657 patients with CIS with stepwise Cox proportional hazards regression models considering second attack as the outcome. Step 2: We established 2 dissemination in space (DIS) versions according to the periventricular lesion cutoffs of ≥1 and ≥3 and assessed their performance at 10 years with second attack as the outcome, first individually and then combined with dissemination in time (DIT) in all cases (n = 326), by age, and by CIS topography. Step 1: The models (hazard ratios [95% confidence interval]) favored ≥1 over ≥3 periventricular lesions (2.5 [1.7-3.6]) and cortico-juxtacortical over juxtacortical lesions (1.4 [1.0-1.8]). Callosal lesions were not selected. Step 2: DIS specificity with ≥1 periventricular lesions was slightly lower than with ≥3 (59.1 vs 61.4) and the same after adding DIT (88.6). Regarding age, ≥3 periventricular lesions improved DIS specificity over ≥1 lesions in the 40-49 years of age bracket (66.7 vs 58.3). This difference disappeared when adding DIT (83.3). Optic neuritis had a similar pattern when evaluating CIS topographies. Our results comply with the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) consensus recommendation of combining cortical and juxtacortical lesions into a single term when possible. Concerning periventricular lesions, maintaining the current ≥1 cutoff in the McDonald criteria does not compromise specificity in typical CIS cases, but attention should be paid to older patients or optic neuritis cases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

  • Salvo-Romero, Eloísa
  • Martínez, Cristina|||0000-0002-9368-1356
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Fortea, Marina|||0000-0001-8885-7495
  • Pardo-Camacho, Cristina
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Farré, Ricard|||0000-0001-7158-171X
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • Vicario Perez, Maria|||0000-0001-9622-3185
Corticotropin-releasing factor (CRF) has been identified in intestinal mucosal eosinophils and associated with psychological stress and gut dysfunction. Irritable bowel syndrome (IBS) is commonly characterized by altered intestinal motility, immune activation, and increased gut barrier permeability along with heightened susceptibility to psychosocial stress. Despite intensive research, the role of mucosal eosinophils in stress-associated gut dysfunction remains uncertain. In this study, we evaluated eosinophil activation profile and CRF content in the jejunal mucosa of diarrhea-predominant IBS (IBS-D) and healthy controls (HC) by gene/protein expression and transmission electron microscopy. We also explored the association between intestinal eosinophil CRF and chronic stress, and the potential mechanisms underlying the stress response by assessing eosinophil response to neuropeptides. We found that mucosal eosinophils displayed higher degranulation profile in IBS-D as compared to HC, with increased content of CRF in the cytoplasmic granules, which significantly correlated with IBS clinical severity, life stress background and depression. Eosinophils responded to substance P and carbachol by increasing secretory activity and CRF synthesis and release, without promoting pro-inflammatory activity, a profile similar to that found in mucosal eosinophils from IBS-D. Collectively, our results suggest that intestinal mucosal eosinophils are potential contributors to stress-mediated gut dysfunction through CRF production and release.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acute Stress Regulates Sex-Related Molecular Responses in the Human Jejunal Mucosa, Implications for Irritable Bowel Syndrome

  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Salvo-Romero, Eloísa
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Galan Soldevilla, Carmen
  • de Torres, Inés|||0000-0002-5495-9140
  • Pribic, Teodora|||0000-0002-3132-7757
  • Hernández, Laura
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Fortea, Marina|||0000-0001-8885-7495
  • Gallart, Milagros
  • Pardo-Camacho, Cristina
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Santos, Javier|||0000-0002-4798-5033
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder linked to intestinal barrier dysfunction and life stress. We have previously reported that female sex per se determines an increased susceptibility to intestinal barrier dysfunction after cold pain stress (CPS). We aimed to identify sex-related molecular differences in response to CPS in healthy subjects to understand the origin of sex bias predominance in IBS. In 13 healthy males and 21 females, two consecutive jejunal biopsies were obtained using Watson's capsule, at baseline, and ninety minutes after CPS. Total mucosal RNA and protein were isolated from jejunal biopsies. Expression of genes related to epithelial barrier (CLDN1, CLDN2, OCLN, ZO-1, and ZO-3), mast cell (MC) activation (TPSAB1, SERPINA1), and the glucocorticoid receptor (NR3C1) were analyzed using RT-qPCR. NR3C1, ZO-1 and OCLN protein expression were evaluated through immunohistochemistry and western blot, and mucosal inflammation through MC, lymphocyte, and eosinophil numbering. Autonomic, hormonal, and psychological responses to CPS were monitored. We found an increase in jejunal MCs, a reduced CLDN1 and OCLN expression, and an increased CLDN2 and SERPINA1 expression 90 min after CPS. We also found a significant decrease in ZO-1, OCLN, and NR3C1 gene expression, and a decrease in OCLN protein expression only in females, when compared to males. CPS induced a significant increase in blood pressure, plasma cortisol and ACTH, and subjective stress perception in all participants. Specific and independent sex-related molecular responses in epithelial barrier regulation are unraveled by acute stress in the jejunum of healthy subjects and may partially explain female predominance in IBS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews, A methodological survey

  • Akl, Elie A.|||0000-0002-3444-8618
  • Carrasco-Labra, Alonso|||0000-0003-3546-3526
  • Brignardello-Petersen, Romina|||0000-0002-6010-9900
  • Neumann, Ignacio|||0000-0001-8406-6880
  • Johnston, Bradley C.|||0000-0001-8872-8626
  • Sun, Xin
  • Briel, Matthias|||0000-0002-2070-5230
  • Busse, Jason|||0000-0002-0178-8712
  • Ebrahim, Shanil
  • Granados, Carlos E.|||0000-0002-1663-4273
  • Iorio, Alfonso|||0000-0002-3331-8766
  • Irfan, Affan B.
  • Martínez García, Laura|||0000-0003-0126-8706
  • Mustafa, Reem|||0000-0002-2091-0875
  • Ramírez-Morera, Anggie|||0000-0003-0793-4626
  • Selva, Anna|||0000-0002-2754-3158
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Juliana Sanabria, Andrea
  • Tikkinen, Kari A. O.
  • Vandvik, Per Olav|||0000-0001-8958-2710
  • Vernooij, Robin W. M.|||0000-0001-5734-4566
  • Zazueta, Oscar E.|||0000-0001-5374-3906
  • Zhou, Qi
  • Guyatt, Gordon|||0000-0003-2352-5718
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Objectives: To describe how systematic reviewers are reporting missing data for dichotomous outcomes, handling them in the analysis and assessing the risk of associated bias. Methods: We searched MEDLINE and the Cochrane Database of Systematic Reviews for systematic reviews of randomised trials published in 2010, and reporting a meta-analysis of a dichotomous outcome. We randomly selected 98 Cochrane and 104 non-Cochrane systematic reviews. Teams of 2 reviewers selected eligible studies and abstracted data independently and in duplicate using standardised, piloted forms with accompanying instructions. We conducted regression analyses to explore factors associated with using complete case analysis and with judging the risk of bias associated with missing participant data. Results: Of Cochrane and non-Cochrane reviews, 47% and 7% (p<0.0001), respectively, reported on the number of participants with missing data, and 41% and 9% reported a plan for handling missing categorical data. The 2 most reported approaches for handling missing data were complete case analysis (8.5%, out of the 202 reviews) and assuming no participants with missing data had the event (4%). The use of complete case analysis was associated only with Cochrane reviews (relative to non-Cochrane: OR=7.25; 95% CI 1.58 to 33.3, p=0.01). 65% of reviews assessed risk of bias associated with missing data; this was associated with Cochrane reviews (relative to non-Cochrane: OR=6.63; 95% CI 2.50 to 17.57, p=0.0001), and the use of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology (OR=5.02; 95% CI 1.02 to 24.75, p=0.047). Conclusions: Though Cochrane reviews are somewhat less problematic, most Cochrane and non-Cochrane systematic reviews fail to adequately report and handle missing data, potentially resulting in misleading judgements regarding risk of bias.